Efficacy of imatinib mesylate-based front-line therapy in pediatric chronic myelogenous leukemia
Hyun Jin Oh (Oh HJ), Mun Sung Cho (Cho MS), Jae Wook Lee (Lee JW), Pil-Sang Jang (Jang PS), Nack-Gyun Chung (Chung NG), Bin Cho (Cho B), Hack-Ki Kim (Kim HK)
Clin Exp Pediatr. 2013;56(8):343-350.   Published online 2013 Aug 27     DOI: https://doi.org/10.3345/kjp.2013.56.8.343
Citations to this article as recorded by Crossref logo
Infectious Complications of Targeted Therapies in Children with Leukemias and Lymphomas
Ioannis Kyriakidis, Elpis Mantadakis, Eftichia Stiakaki, Andreas H. Groll, Athanasios Tragiannidis
Cancers.2022; 14(20): 5022.     CrossRef
Horn of plenty: Value of the international registry for pediatric chronic myeloid leukemia
Meinolf Suttorp, Markus Metzler, Frédéric Millot
World Journal of Clinical Oncology.2020; 11(6): 308.     CrossRef
Optimal management for pediatric chronic myeloid leukemia
Akihiko Tanizawa
Pediatrics International.2016; 58(3): 171.     CrossRef
Leucémie myéloïde chronique des sujets jeunes : expérience dans une unité d’hématologie clinique au Sénégal
S. Fall, F.S.D. Ndiaye, O.D. Dior, A.F. Sall, I. Sloma, A. Touré-Fall, Y. Keita
Revue d'Oncologie Hématologie Pédiatrique.2015; 3(4): 170.     CrossRef